Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
- 21 January 1999
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 365 (1) , 9-25
- https://doi.org/10.1016/s0014-2999(98)00788-2
Abstract
No abstract availableKeywords
This publication has 226 references indexed in Scilit:
- The A3Adenosine Receptor Mediates Cell Spreading, Reorganization of Actin Cytoskeleton, and Distribution of Bcl-xL: Studies in Human Astroglioma CellsBiochemical and Biophysical Research Communications, 1997
- Acute Ischemic Stroke TherapyEuropean Neurology, 1997
- Adenosine A2b Receptors Mediate an Increase in Interleukin (IL)‐6 mRNA and IL‐6 Protein Synthesis in Human Astroglioma CellsJournal of Neurochemistry, 1996
- Exercise, Training and Red Blood Cell TurnoverSports Medicine, 1995
- CGS 15943, An adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbilLife Sciences, 1994
- Propentofylline: A nucleoside transport inhibitor with neuroprotective effects in cerebral ischemiaGeneral Pharmacology: The Vascular System, 1994
- Persistently enhanced ratio of NMDA and non-NMDA components of rat hippocampal EPSC after block of A1 adenosine receptors at increased [Ca2+]o[Mg2+]oNeuroscience Letters, 1994
- Alteration of adenosine A1 receptor binding in the post-ischaemic rat brainNeuroReport, 1994
- The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortexNeuroscience Letters, 1992
- Adenosine depression of hippocampal neurons in vitro: An intracellular study of dose-dependent actions on synaptic and membrane potentialsNeuroscience Letters, 1981